533 related articles for article (PubMed ID: 27592129)
1. American Brachytherapy Society Task Group Report: Combined external beam irradiation and interstitial brachytherapy for base of tongue tumors and other head and neck sites in the era of new technologies.
Takácsi-Nagy Z; Martínez-Mongue R; Mazeron JJ; Anker CJ; Harrison LB
Brachytherapy; 2017; 16(1):44-58. PubMed ID: 27592129
[TBL] [Abstract][Full Text] [Related]
2. Interstitial brachytherapy for stage I and II squamous cell carcinoma of the oral tongue: factors influencing local control and soft tissue complications.
Fujita M; Hirokawa Y; Kashiwado K; Akagi Y; Kashimoto K; Kiriu H; Matsuura K; Ito K
Int J Radiat Oncol Biol Phys; 1999 Jul; 44(4):767-75. PubMed ID: 10386633
[TBL] [Abstract][Full Text] [Related]
3. [Brachytherapy of head and neck cancer].
Takácsi Nagy Z; Kásler M
Magy Onkol; 2008 Jun; 52(2):145-50. PubMed ID: 18640890
[TBL] [Abstract][Full Text] [Related]
4. An analysis of mandibular bone complications in radiotherapy for T1 and T2 carcinoma of the oral tongue.
Fujita M; Hirokawa Y; Kashiwado K; Akagi Y; Kashimoto K; Kiriu H; Ohtani K; Wada T
Int J Radiat Oncol Biol Phys; 1996 Jan; 34(2):333-9. PubMed ID: 8567334
[TBL] [Abstract][Full Text] [Related]
5. Interstitial high-dose-rate brachytherapy in the treatment of base of tongue carcinoma.
Takácsi-Nagy Z; Polgár C; Oberna F; Somogyi A; Major T; Remenár E; Fodor J; Kásler M; Németh G
Strahlenther Onkol; 2004 Dec; 180(12):768-75. PubMed ID: 15592696
[TBL] [Abstract][Full Text] [Related]
6. Treatment outcome with low-dose-rate interstitial brachytherapy in early-stage oral tongue cancers.
Bhalavat RI; Mahantshetty UM; Tole S; Jamema SV
J Cancer Res Ther; 2009; 5(3):192-7. PubMed ID: 19841561
[TBL] [Abstract][Full Text] [Related]
7. [Brachytherapy in head and neck cancers].
Mazeron JJ; Noël G; Simon JM; Racadot S; Jauffret E
Cancer Radiother; 2003 Feb; 7(1):62-72. PubMed ID: 12648718
[TBL] [Abstract][Full Text] [Related]
8. Brachytherapy versus surgery in carcinoma of tonsillar fossa and/or soft palate: late adverse sequelae and performance status: can we be more selective and obtain better tissue sparing?
Levendag P; Nijdam W; Noever I; Schmitz P; van de Pol M; Sipkema D; Braat C; de Boer M; Jansen P
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):713-24. PubMed ID: 15183475
[TBL] [Abstract][Full Text] [Related]
9. Long-term outcomes after external beam irradiation and brachytherapy boost for base-of-tongue cancers.
Gibbs IC; Le QT; Shah RD; Terris DJ; Fee WE; Goffinet DR
Int J Radiat Oncol Biol Phys; 2003 Oct; 57(2):489-94. PubMed ID: 12957261
[TBL] [Abstract][Full Text] [Related]
10. Patterns of care and impact of brachytherapy boost utilization for squamous cell carcinoma of the base of tongue in a large, national cohort.
Lee A; Givi B; Wu SP; Tam MM; Gerber NK; Hu KS; Han P; Schreiber D
Brachytherapy; 2017; 16(6):1205-1212. PubMed ID: 28943128
[TBL] [Abstract][Full Text] [Related]
11. Definitive radiotherapy with interstitial implant boost for squamous cell carcinoma of the tongue base.
Karakoyun-Celik O; Norris CM; Tishler R; Mahadevan A; Clark JR; Goldberg S; Devlin P; Busse PM
Head Neck; 2005 May; 27(5):353-61. PubMed ID: 15726587
[TBL] [Abstract][Full Text] [Related]
12. The role of brachytherapy in the treatment of squamous cell carcinoma of the head and neck.
Wierzbicka M; Bartochowska A; Strnad V; Strojan P; Mendenhall WM; Harrison LB; Rinaldo A; Sahai P; Wiegand S; Ferlito A
Eur Arch Otorhinolaryngol; 2016 Feb; 273(2):269-76. PubMed ID: 25338181
[TBL] [Abstract][Full Text] [Related]
13. Re-irradiation with interstitial pulsed-dose-rate brachytherapy for unresectable recurrent head and neck carcinoma.
Strnad V; Lotter M; Kreppner S; Fietkau R
Brachytherapy; 2014; 13(2):187-95. PubMed ID: 24211123
[TBL] [Abstract][Full Text] [Related]
14. High-dose-rate interstitial brachytherapy boost in inoperable locally advanced tongue carcinoma.
Santos MA; Guinot JL; Tortajada MI; Santamaría P; Campo V; Oliver L; Peña M; Arribas L
Brachytherapy; 2017; 16(6):1213-1218. PubMed ID: 28807749
[TBL] [Abstract][Full Text] [Related]
15. The importance of interstitial radiotherapy in the treatment of the base of tongue tumors: a retrospective analysis.
Takácsi-Nagy Z; Oberna F; Polgár C; Somogyi A; Major T; Németh G
Neoplasma; 2001; 48(1):76-81. PubMed ID: 11327543
[TBL] [Abstract][Full Text] [Related]
16. Preliminary report of pulsed dose rate brachytherapy in head-and-neck cancer.
Ziemlewski A; Zienkiewicz J; Serkies K; Badzio A
Strahlenther Onkol; 2007 Sep; 183(9):512-6. PubMed ID: 17762926
[TBL] [Abstract][Full Text] [Related]
17. High-dose-rate interstitial brachytherapy in recurrent and previously irradiated head and neck cancers--preliminary results.
Narayana A; Cohen GN; Zaider M; Chan K; Lee N; Wong RJ; Boyle J; Shaha A; Kraus D; Shah J; Zelefsky MJ
Brachytherapy; 2007; 6(2):157-63. PubMed ID: 17434110
[TBL] [Abstract][Full Text] [Related]
18. Excellent functional outcome in patients with squamous cell carcinoma of the base of tongue treated with external irradiation and interstitial iodine 125 boost.
Horwitz EM; Frazier AJ; Martinez AA; Keidan RD; Clarke DH; Lacerna MD; Gustafson GS; Heil E; Dmuchowski CF; Vicini FA
Cancer; 1996 Sep; 78(5):948-57. PubMed ID: 8780531
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcomes with high-dose-rate brachytherapy for the management of base of tongue cancer.
Takácsi-Nagy Z; Oberna F; Koltai P; Hitre E; Major T; Fodor J; Polgár C
Brachytherapy; 2013; 12(6):535-41. PubMed ID: 23988507
[TBL] [Abstract][Full Text] [Related]
20. [Time, dose and volume factors in interstitial brachytherapy combined with external irradiation for oral tongue carcinoma].
Yorozu A
Nihon Igaku Hoshasen Gakkai Zasshi; 1996 Apr; 56(5):303-10. PubMed ID: 8692656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]